This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:physicians:emergency [09.16.2017] – [Notice for emergency medical personnel] sallieq | home:physicians:emergency [11.21.2018] – [Notice for emergency medical personnel] sallieq | ||
---|---|---|---|
Line 46: | Line 46: | ||
**Do not give** corticosteroids in any form or by any route (injected, inhaled, oral or IV) as they | **Do not give** corticosteroids in any form or by any route (injected, inhaled, oral or IV) as they | ||
will lead to metabolic instability. | will lead to metabolic instability. | ||
- | ** | + | |
- | Do not give Telmisartan**, | + | **Do not give Telmisartan**, |
**Do not give nimesulide** (Aulin / Mesulid / Nimed). | **Do not give nimesulide** (Aulin / Mesulid / Nimed). | ||
Line 53: | Line 53: | ||
Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. | Xarelto increases the risk of bleeding and can cause serious or fatal bleeding. | ||
**A specific antidote for rivaroxaban is not available.** | **A specific antidote for rivaroxaban is not available.** | ||
+ | |||
+ | Colistin (Colimycin, Colisticin, Colistin Sulfate, Coly-Mycin, Polymyxin ESulfate, Totazina) is not suitable for treating MP patients. | ||
Adverse reactions may occur if epinephrine or norepinephrine | Adverse reactions may occur if epinephrine or norepinephrine |